NeoStem’s Suzhou Erye Receives 2 Pharma Industry Awards, Positioned For Future Growth
NeoStem announced Tuesday that Chinese generic pharma company Suzhou Erye, in which it owns a 51% majority stake, has won two awards at the 2011 Chempharm Brand Summit.